MMP-9 is increased in the hearts of dystrophin-deficient mdx mice, which possess point mutation in the Duchenne muscular dystrophy-related gene, and genetic ablation of MMP9 diminishes the activation of ERK1/2 and Akt kinase followed by an improvement in cardiac function [124]. This evidence concerns the gene MMP9 and Duchenne muscular dystrophy.